Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 432

    Online Pharmacy, Myra Medicines receives funds from Matrix Partners and Times Internet

    Online Pharmacy, Myra Medicines receives funds from Matrix Partners and Times Internet

    savita thakur thakur3 May 2017 12:01 PM IST
    Bengaluru: Myra Medicines, a Bengaluru based startup e-pharma company is learnt to have raised about 7-8 million dollars from Matrix Partners and...
    SeQuents arm Alivira gets USFDA nod for Visakhapatnam API facility

    SeQuent's arm Alivira gets USFDA nod for Visakhapatnam API facility

    Ruby Khatun Khatun3 May 2017 11:53 AM IST
    New Delhi: Drug firm SeQuent Scientific said its arm Alivira has received approval from the US health regulator for its animal health API facility in...
    FDA OKs immune-boosting drug for advanced bladder cancer

    FDA OKs immune-boosting drug for advanced bladder cancer

    Ruby Khatun Khatun3 May 2017 10:14 AM IST
    TRENTON, N.J.: U.S. regulators have approved a new drug that harnesses the immune system to treat bladder cancer that has spread after chemotherapy...
    AstraZeneca immunotherapy wins first approval in bladder cancer

    AstraZeneca immunotherapy wins first approval in bladder cancer

    Ruby Khatun Khatun3 May 2017 9:23 AM IST
    By Ben Hirschler, Divya and GroverU.S. regulators have approved AstraZeneca's key immunotherapy drug durvalumab as a treatment for bladder cancer,...
    HC notice to SBI on plea for reimbursing cancer drug cost

    HC notice to SBI on plea for reimbursing cancer drug cost

    Ruby Khatun Khatun2 May 2017 11:26 AM IST
    Mumbai: The Bombay High Court has sought the SBI stand on a senior citizen's plea for reimbursement of Rs six lakh as the cost of importing a cancer...
    Stent makers demand government to apply differential pricing for Drug-eluting stents

    Stent makers demand government to apply differential pricing for Drug-eluting stents

    Ruby Khatun Khatun2 May 2017 11:24 AM IST
    New Delhi: Stent manufacturers want the government to apply differential pricing for drug-eluting stents by classifying them on the basis of...
    FDA approves first treatment for a form of Batten disease

    FDA approves first treatment for a form of Batten disease

    supriya kashyap kashyap2 May 2017 11:15 AM IST
    The U.S. Food and Drug Administration approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first...
    FDA approves Radius Healths osteoporosis drug Tymlos

    FDA approves Radius Health's osteoporosis drug Tymlos

    Ruby Khatun Khatun2 May 2017 11:14 AM IST
    The U.S. Food and Drug Administration on Friday approved Radius Health Inc's drug to treat osteoporosis in postmenopausal women at high risk of...
    Patanjali to wipe out MNCs from Indian market in 5 years: Ramdev

    Patanjali to wipe out MNCs from Indian market in 5 years: Ramdev

    Ruby Khatun Khatun2 May 2017 11:12 AM IST
    Saharanpur: Yoga guru Ramdev said on Sunday that Patanjali Ayurveda, promoted by him, will steal the march over multinational firms manufacturing...
    U.S. FDA approves Novartis

    U.S. FDA approves Novartis' leukemia treatment

    Ruby Khatun Khatun1 May 2017 11:36 AM IST
    The U.S. Food and Drug Administration approved Novartis AG's Rydapt as an initial treatment for acute myeloid leukemia (AML) as well as certain other...
    USFDA approves Takedas lung cancer drug as second-line treatment

    USFDA approves Takeda's lung cancer drug as second-line treatment

    supriya kashyap kashyap1 May 2017 11:36 AM IST
    Japan's Takeda Pharmaceutical Co Ltd said that the U.S. Food and Drug Administration approved its lung cancer drug, almost three months after the...
    Zydus Cadila gets USFDA nod for anti-cholesterol drug

    Zydus Cadila gets USFDA nod for anti-cholesterol drug

    Ruby Khatun Khatun1 May 2017 9:40 AM IST
    New Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market an anti-cholesterol drug, Cholestyramine, in the...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    MSD India appoints Rehan A Khan as Managing Director

    MSD India appoints Rehan A Khan as Managing Director

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok